FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Home AFib Blood Pressure Monitor De Novo Granted

FDA grants a de novo marketing authorization to Omron Healthcare for its new home blood pressure monitors featuring AI-powered atrial fibrillation det...

latest-news-card-1

Medical Device Recalls Up, Drugs Down: Sedgwick

The Sedgwick third quarter 2024 recall index documents an increase in medical device recalls and a decrease in drug recalls.

latest-news-card-1
Medical Devices

SonoMotion De Novo for Stone Clear Ultrasound

FDA grants SonoMotion a de novo marketing authorization for its Stone Clear device for the ultrasound treatment of post-lithotripsy kidney stone fragm...

latest-news-card-1
Marketing

False or Misleading Xeomin Promotion: FDA

FDA cautions Merz over misleading representations about its Xeomin in a promotional piece featuring celebrity spokesman Nate Berkus.

latest-news-card-1
Human Drugs

Respironics Recalls Garbin Ventilators

Philips Respironics recalls (Class 1) its Garbin Evo ventilators due to the potential for aerosol deposit accumulation on the devices internal flow se...

latest-news-card-1
Human Drugs

Innovative Manufacturing Technologies Comments

Two stakeholder trade associations suggest changes to an FDA strategy document on innovative manufacturing technologies.

latest-news-card-1
FDA General

Trump Taps RFK Jr. as HHS Secretary

President-elect Donald Trump picks controversial FDA critic and vaccine skeptic Robert F. Kennedy Jr. as his secretary for Health and Human Services.

latest-news-card-1
Human Drugs

Require Studies for Prednisolone Eye Drops: DifGen

DifGen asks FDA to require long-term refrigerated stability studies for any generic form of its Prednisolone Ophthalmic Solution 1%.

latest-news-card-1
Human Drugs

Workshop on Patient Experience Data

Federal Register notice: FDA announces a 12/13 virtual public workshop entitled Patient-Focused Drug Development: Workshop to Discuss Methodologic and...

latest-news-card-1
Biologics

Adaptimmune Therapeutics Plan Lete-Cel BLA

Adaptimmune Therapeutics plans a rolling BLA submission for cell therapy lete-cel in certain people with synovial sarcoma or myxoid/round cell liposar...